Abstract
The interaction of zamifenacin ((3 R)-(+)-diphenylmethoxy-1-(3,4)-methylenedioxyphenethyl)piperidine) at muscarinic receptor subtypes was studied using radioligand binding and functional techniques, in vitro. In radioligand binding studies, zamifenacin acted as a competitive antagonist, with the following p K i values; rat cerebral cortex (M 1) 7.90 ± 0.08, myocardium (M 2) 7.93 ± 0.13, submaxillary gland (M 3) 8.52 ± 0.01 and rabbit lung (M 4) 7.78 ± 0.04. In functional studies zamifenacin acted as a surmountable antagonist, exhibiting the following apparent affinity values; canine saphenous vein (putative M 1) 7.93 ± 0.09, guinea-pig left atria (M 2) 6.60 ± 0.04, guinea-pig ileum (M 3) 9.31 ± 0.06, guinea-pig oesophageal muscularis mucosae (M 3) 8.84 ± 0.04, guinea-pig trachea (M 3) 8.16 ± 0.04, and guinea-pig urinary bladder (M 3) 7.57 ± 0.15. Therefore, zamifenacin is selective for muscarinic M 3 receptors in guinea-pig ileum, oesophageal muscularis mucosae, trachea and bladder over muscarinic M 2 receptors in atria. The degree of muscarinic M 3 M 2 receptor selectivity depends upon the muscarinic M 3 receptor preparation studied.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
